Journal
|
KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • HRD (Homologous Recombination Deficiency) • TNFA (Tumor Necrosis Factor-Alpha) • ANXA1 (Annexin A1) • MKI67 (Marker of proliferation Ki-67)
|
TP53 mutation • KRAS mutation • HRD • TP53 expression • ANXA1 expression
|
gemcitabine • 5-fluorouracil • doxorubicin hydrochloride